Evidence map›Paper›PMID 36620646›Full record

ArticleFrontiers in cardiovascular medicine2022

Bifurcation strategies using second-generation drug-eluting stents on clinical outcomes in diabetic patients.

Jung-Joon Cha, Soon Jun Hong, Ju Hyeon Kim, Subin Lim, Hyung Joon Joo, Jae Hyoung Park, Cheol Woong Yu, Jeehoon Kang, Hyo-Soo Kim, Hyeon-Cheol Gwon and 23 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03068494 (Multicenter, Retrospective Korean Coronary Bifurcation Stenting), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 68% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03068494 completednot on this map

Multicenter, Retrospective Korean Coronary Bifurcation Stenting (COBIS) Registry III

Typeobservational_patient_registrySponsorSamsung Medical CenterRan2017 to 2018Enrolled2,648ConditionsCoronary Bifurcation Lesion
3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors at 20 institutions in 1 country.

Jung-Joon ChaDivision of Cardiology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, South Korea.
Soon Jun HongDivision of Cardiology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, South Korea.
Ju Hyeon KimDivision of Cardiology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, South Korea.
Subin LimDivision of Cardiology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, South Korea.
Hyung Joon JooDivision of Cardiology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, South Korea.
Jae Hyoung ParkDivision of Cardiology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, South Korea.
Cheol Woong YuDivision of Cardiology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, South Korea.
Jeehoon KangDepartment of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, South Korea.
Hyo-Soo KimDepartment of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, South Korea.
Hyeon-Cheol GwonDepartment of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Woo Jung ChunDepartment of Internal Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, South Korea.
Seung-Ho HurDepartment of Internal Medicine, Keimyung University Dongsan Medical Center, Daegu, South Korea.
Seung Hwan HanDepartment of Internal Medicine, Gachon University Gil Hospital, Incheon, South Korea.
Seung-Woon RhaDepartment of Internal Medicine, Korea University Guro Hospital, Seoul, South Korea.
In-Ho ChaeDepartment of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea.
Jin-Ok JeongDepartment of Medicine, Chungnam National University Hospital, Daejeon, South Korea.
Jung Ho HeoDepartment of Internal Medicine, Kosin University Gospel Hospital, Kosin University College of Medicine, Pusan, South Korea.
Junghan YoonDepartment of Internal Medicine, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, Wonju, South Korea.
Jong-Seon ParkDepartment of Internal Medicine, Yeungnam University Medical Center, Daegu, South Korea.
Myeong-Ki HongDepartment of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, South Korea.
Joon-Hyung DohDepartment of Internal Medicine, Inje University Ilsan Paik Hospital, Ilsan, South Korea.
Kwang Soo ChaDepartment of Internal Medicine, Pusan National University Hospital, Pusan, South Korea.
Doo-Il KimDepartment of Internal Medicine, Inje University Haeundae Paik Hospital, Pusan, South Korea.
Sang Yeub LeeDepartment of Cardiology, Chung-Ang University, College of Medicine Heart and Brain Hospital, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong, South Korea.
Kiyuk ChangDepartment of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, South Korea.
Byung-Hee HwangDepartment of Internal Medicine, St. Paul's Hospital, The Catholic University of Korea, Seoul, South Korea.
So-Yeon ChoiDepartment of Internal Medicine, Ajou University Hospital, Suwon, South Korea.
Myung Ho JeongDepartment of Internal Medicine, Chonnam National University Hospital, Gwangju, South Korea.
Young Bin SongDepartment of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Ki Hong ChoiDepartment of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Chang-Wook NamDepartment of Internal Medicine, Keimyung University Dongsan Medical Center, Daegu, South Korea.
Bon-Kwon KooDepartment of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, South Korea.
Do-Sun LimDivision of Cardiology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, South Korea.
Korea University Medical Center · KRSeoul National University Hospital · KRSungkyunkwan University · KRAjou University Hospital · KRChonnam National University Hospital · KRChung-Ang University · KRChungnam National University Hospital · KRDeleted InstitutionInje University Haeundae Paik Hospital · KRInje University Ilsan Paik Hospital · KRKeimyung University · KRKeimyung University Dongsan Medical Center · KRKosin University Gospel Hospital · KRPusan National University Hospital · KRSamsung Medical Center · KRSeoul National University Bundang Hospital · KRSt. Paul's Hospital · KRThe Catholic University of Korea Seoul St. Mary's Hospital · KRWonju Severance Christian Hospital · KRYeungnam University Medical Center · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Diabetes mellitus (DM) is a critical risk factor for the pathogenesis and progression of coronary artery disease, with a higher prevalence of complex coronary artery disease, including bifurcation lesions. This study aimed to elucidate the optimal stenting strategy for coronary bifurcation lesions in patients with DM. Methods: A total of 905 patients with DM and bifurcation lesions treated with second-generation drug-eluting stents (DES) from a multicenter retrospective patient cohort were analyzed. The primary outcome was the 5-year incidence of target lesion failure (TLF), which was defined as a composite of cardiac death, target vessel myocardial infarction, and target lesion revascularization. Results: Among all patients with DM with significant bifurcation lesions, 729 (80.6%) and 176 (19.4%) were treated with one- and two-stent strategies, respectively. TLF incidence differed according to the stenting strategy during the mean follow-up of 42 ± 20 months. Among the stent strategies, T- and V-stents were associated with a higher TLF incidence than one-stent strategy (24.0 vs. 7.3%, Conclusion: T- or V-stenting in patients with DM resulted in increased cardiovascular events after second-generation DES implantation. Clinical trial registration: https://clinicaltrials.gov/ct2/show/NCT03068494?term=03068494&draw=2&rank=1, identifier: NCT03068494.

Indexed as

clinical outcomecoronary bifurcation angioplastydiabetes mellituspercutaneous coronary intervention (complex PCI)second-generation drug-eluting stentstent strategy

Identifiers

PMID36620646
PMCPMC9811589
OpenAlexW4313466891

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.